| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chairman and CEO
2 companies
Vivek Jain is Chairman and CEO at ICUI, with reported holdings spanning 2 companies. Vivek Jain's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $21.8M at current prices.
Our model assigns Vivek Jain a strong insider score of 83/100, based on 14 past trades. Over a 12-month horizon, all 14 of those trades were profitable, with an average 12-month return of +31.3%.
Vivek Jain's largest disclosed position is in ICUI as Chairman and CEO, worth about $20.5M. The ICUI filings lean toward selling, a net 554,444 shares.
Vivek Jain has 70 Form 4 filings on record from February 2015 to May 2026, across 2 companies: Director at Envista (NVST), 2020–2026; Chairman and CEO at ICU Medical (ICUI), 2015–2026.
The 225 reported transactions were 76 option exercises, 69 open-market sales, 40 tax withholdings and 13 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $2.5M and 25 sales worth about $110.9M.
The only open-market purchase was 21,929 shares of ICUI at an average $112.84 on August 14, 2025, about $2.5M. Twelve months later ICUI was up 64%.
The largest open-market sale was 97,795 shares of ICUI at an average $190.00 on October 20, 2017, about $18.6M.
All 8 sales since April 2023 were made under a Rule 10b5-1 trading plan, set up in advance.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | ICUI Icu Medical Inc/de | Chairman and CEO | Buy | 21,929 | $112.84 | $2,474,374.52 | +20.3% | +24.4% | +63.5% | |
| Jan 2, 2025 | ICUI Icu Medical Inc/de | Chairman and CEO | Sale+OE10b5-1 | 1,373 | $155.48 | $213,474.04 | -1.3% | -11.1% | -12.3% | |
| Dec 2, 2024 | ICUI Icu Medical Inc/de | Chairman and CEO | Sale+OE10b5-1 | 12,000 | $162.91 | $1,954,934.51 | -10.3% | -12.1% | -8.9% | |
| Nov 1, 2024 | ICUI Icu Medical Inc/de | Chairman and CEO | Sale+OE10b5-1 | 12,000 | $171.84 | $2,062,136.38 | -10.3% | -2.9% | -29.7% | |
| Oct 1, 2024 | ICUI Icu Medical Inc/de | Chairman and CEO | Sale+OE10b5-1 | 12,000 | $178.46 | $2,141,579.92 | -10.3% | -13.9% | -32.5% | |
| Sep 3, 2024 | ICUI Icu Medical Inc/de | Chairman and CEO | Sale+OE10b5-1 | 12,000 | $163.46 | $1,961,540.40 | -10.3% | -1.3% | -23.9% | |
| Aug 16, 2024 | ICUI Icu Medical Inc/de | Chairman and CEO | Sale+OE10b5-1 | 12,000 | $156.04 | $1,872,480.00 | -10.3% | +8.5% | -23.7% | |
| Jul 12, 2023 | ICUI Icu Medical Inc/de | Chairman and CEO | Sale+OE10b5-1 | 30,000 | $180.02 | $5,400,720.00 | -55.9% | -33.6% | -28.6% | |
| Jun 14, 2023 | ICUI Icu Medical Inc/de | Chairman and CEO | Sale+OE10b5-1 | 30,000 | $188.67 | $5,660,085.55 | -55.9% | -33.1% | -39.0% | |
| Mar 3, 2022 | ICUI Icu Medical Inc/de | Chairman and CEO | Sale+OE | 36,000 | $240.00 | $8,640,000.00 | -73.8% | -25.1% | -29.3% |